Upon his resignation, Calafiore’s responsibilities will be reallocated among the executive management team while the company aligns its commercial structure.
“On behalf of the NuVasive team, I would like to thank Massimo for his impact on our organization,” CEO Chris Barry said in a news release. “He has accomplished much during his tenure at NuVasive and we wish him great success in his new opportunity.”
Calfiore has been with the company since June 2017. Prior to that, he held numerous leadership roles at Waldemar Link.
“In my five years at NuVasive, I am very proud of our collective work to transform surgery, advance care and most importantly—change the lives of patients around the world. NuVasive is an amazing company, and I’m excited to see what it will accomplish through bringing world-class, innovative technology to market,” Calafiore said.